MDA Action Center
Welcome to the MDA Action Center, your destination for the most important scientific advances, clinical updates, and emerging themes presented at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. Designed for neurologists and healthcare professionals who care for individuals with neuromuscular diseases, this series distills high-impact sessions into clinically relevant insights you can apply in practice today.
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
NeuroFrontiersEarly ALS Patients Show Slowed Decline with Pridopidine Treatment
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
NeuroFrontiersGFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
- advertisement
- 03/04/2026
- 03/04/2026
- 02/27/2026